Drug Company Won’t Study $60 Replacement for $2000 Eye Treatment
Thursday, August 28th, 2008“What does a company do when there is anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000? In the case of Genentech Inc., nothing.”
Read the entire AP article here.
Note that these drugs are primarily [...]

